Company Filing History:
Years Active: 2001-2007
Title: Arjun Singh: Innovator in Recombinant DNA Technology
Introduction
Arjun Singh is a notable inventor based in Pacifica, CA (US). He has made significant contributions to the field of biotechnology, particularly in recombinant DNA technology. With a total of 2 patents, his work has advanced the understanding and application of yeast expression systems and human insulin-like growth factor synthesis.
Latest Patents
Arjun Singh's latest patents include the following:
1. **Use of alpha factor sequences in yeast expression systems** - This patent describes the isolation of the yeast α-factor genes. The promoter and signal peptide portions are isolated and joined to DNA coding for proteins heterologous to yeast in a plasmid, which is used to transform yeast cells. The yeast expresses the heterologous DNA and processes and secretes the heterologous protein.
2. **Preparation of human IGF via recombinant DNA technology** - This patent details the synthesis of human insulin-like growth factor in recombinant cell culture by host cells transformed with expression vectors bearing DNA encoding human insulin-like growth factor.
Career Highlights
Arjun Singh is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to drug development. His work at Genentech has allowed him to collaborate with some of the brightest minds in the industry.
Collaborations
Some of his notable coworkers include James M Lee and Axel Ullrich. Their combined expertise has contributed to the success of various projects within the company.
Conclusion
Arjun Singh's contributions to biotechnology through his patents and work at Genentech, Inc. highlight his role as an innovator in the field. His advancements in recombinant DNA technology continue to impact the industry positively.